Double-blind comparisons of zomepirac and oxycodone with APC in cancer pain.
D000328:Adult; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002110:Caffeine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003061:Codeine / Q000031:analogs & derivatives*; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010098:Oxycodone / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010615:Phenacetin / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D014046:Tolmetin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
D000700:Analgesics; D004338:Drug Combinations; D011758:Pyrroles; D002110:Caffeine; C020549:zomepirac; D010098:Oxycodone; D014046:Tolmetin; D010615:Phenacetin; D001241:Aspirin; D003061:Codeine